Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1996-12-19
1998-09-22
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
424692, 514254, A61K 3332, A61K 3308, A61K 31495, A61K 3150
Patent
active
058111301
ABSTRACT:
Aqueous pharmaceutical solutions suitable for injection into a host, having improved injection site toleration, comprise danofloxacin or its pharmaceutically acceptable salts and a magnesium or zinc compound. The zinc compound in addition requires the presence of a co-solvent.
REFERENCES:
patent: 4772605 (1988-09-01), Naik et al.
patent: 5082863 (1992-01-01), Apelian et al.
patent: 5084276 (1992-01-01), Yunker et al.
patent: 5223246 (1993-06-01), Kondo et al.
patent: 5334589 (1994-08-01), Al-Razzak et al.
Boettner Wayne A.
Canning Peter C.
Ginsburg Paul H.
Holtrust Gezina
Jordan Kimberly
Pfizer Inc.
Richardson Peter C.
LandOfFree
Injectable quinolone formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable quinolone formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable quinolone formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1620324